|
C9ORF85 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.547400E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.854400E-01 |
| Normal-vs-Stage2 |
4.913800E-01 |
| Normal-vs-Stage3 |
9.516600E-01 |
| Normal-vs-Stage4 |
4.019400E-01 |
| Stage1-vs-Stage2 |
8.645400E-01 |
| Stage1-vs-Stage3 |
3.273800E-01 |
| Stage1-vs-Stage4 |
2.088200E-01 |
| Stage2-vs-Stage3 |
5.863600E-01 |
| Stage2-vs-Stage4 |
2.930400E-01 |
| Stage3-vs-Stage4 |
6.214800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.459200E-01 |
| Normal-vs-AfricanAmerican |
7.868800E-01 |
| Normal-vs-Asian |
8.096600E-01 |
| Caucasian-vs-AfricanAmerican |
6.793600E-01 |
| Caucasian-vs-Asian |
9.635600E-01 |
| AfricanAmerican-vs-Asian |
8.420800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.053200E-01 |
| Normal-vs-Female |
5.619600E-01 |
| Male-vs-Female |
7.804100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.235400E-01 |
| Normal-vs-Extreme_Weight |
1.588610E-01 |
| Normal-vs-Obese |
8.127800E-01 |
| Normal-vs-Extreme_Obese |
1.252850E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.054200E-01 |
| Normal_Weight-vs-Obese |
6.785000E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.711000E-01 |
| Extreme_Weight-vs-Obese |
1.198210E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.970800E-01 |
| Obese-vs-Extreme_Obese |
2.184800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.076600E-01 |
| Normal-vs-Age(41-60Yrs) |
4.659800E-01 |
| Normal-vs-Age(61-80Yrs) |
1.560150E-01 |
| Normal-vs-Age(81-100Yrs) |
2.403600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.416400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.583200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.674600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.218000E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.515180E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.832600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.844600E-01 |
| Normal-VS-Type2 PRCC |
2.140000E-01 |
| Normal-VS-KIRP CIMP |
6.152200E-01 |
| Normal-VS-Unclassified PRCC |
1.507760E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.503800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.617400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.101170E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.624000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
7.278200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.820620E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.641650E-01 |
| Normal-vs-N1 |
5.019200E-01 |
| Normal-vs-N2 |
1.334030E-01 |
| N0-vs-N1 |
1.058840E-01 |
| N0-vs-N2 |
6.232800E-01 |
| N1-vs-N2 |
2.736400E-01 |
|
|
